Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis

Read full text
Authors: Xian‐Yang Qin, Yali Xu, Hricha Mishra, Yohei Shirakami, Shiou-Hwei Yeh, Chiao-Ling Li, K. Numata, Yusuke Suenaga, Feifei Wei, Reiko Ando, Hajime Nishimura, Erina Furuhata
+14 more Shiori Maeda, Yutaka Furutani, Kaori Yanaka, Masahiro Yamamoto, Masanori Goto, Akira Takasawa, Yuji Nishikawa, Hiroyuki Tomita, Luc Gailhouste, Tomokazu Matsuura, Pei‐Jer Chen, Masao Shimizu, Yoshitaka Hippo, Harukazu Suzuki
Cited by: 3
References: 53

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. It is often diagnosed at advanced stages and characterized by high recurrence rates. Although chronic liver inflammation and metabolic dysfunction are established contributors to tumorigenesis, the molecular mechanisms that link microenvironmental stress to malignant transformation remain poorly understood. MYCN, a proto-oncogenic transcription factor, has emerged as a potential biomarker of cancer stemness. However, its role in hepatocarcinogenesis remains unclear. In this study, we elucidated the oncogenic role of MYCN and its dynamic transcriptional regulation during liver tumorigenesis. Using a hydrodynamic tail vein injection-based transposon system in mice, we demonstrated that MYCN overexpression synergizes with AKT activation to promote liver tumorigenesis. Transcriptomic profiling revealed that MYCN-driven tumors exhibited features of human HCC subtypes enriched in stress-adaptive transcriptional programs. Time-resolved spatial transcriptomics further uncovered a MYCN-enriched niche characterized by epithelial-mesenchymal transition (EMT) and Wnt/β-catenin signaling, which expanded during tumor progression and was spatially proximate to transformed malignant cells. To translate these findings to human HCC, we developed a machine learning-based MYCN niche score and validated its clinical relevance across multiple human HCC cohorts. This score reliably predicted recurrence risk and identified EMT-prone microenvironments, with stronger predictive performance in nontumor tissues, suggesting its potential in detecting precancerous niches predisposed to de novo tumorigenesis. Collectively, our findings establish MYCN as a functional driver and spatial marker of tumor-promoting microenvironments in liver tumorigenesis; additionally, we propose a clinically actionable strategy to identify high-risk patients through transcriptomic profiling of nontumor liver tissue.

Fields of Study & Subjects

Cancer Cells and Metastasis Wnt/β-catenin signaling in development and cancer Liver physiology and pathology

Publication details

Journal / source
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Volume
123
Issue
8
Pages
e2521923123–e2521923123
Publication date
18 February 2026
Language
EN